Johnson & Johnson

Johnson & Johnson pauses coronavirus vaccine trials due to unexplained illness

  • Such pauses are normal in big trials, which can include tens of thousands of people
  • Last month, J&J said its vaccine candidate produced a strong immune response in an early-to-mid stage clinical trial
By Reuters ·